Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100

Abbott Laboratories (ABT) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Abbott Laboratories (ABT) trades at a P/B ratio of 3.5×. Over the past ten years it has ranged from 2.3× (April 2017) to 7.2× (December 2021); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 4.1× 0.60%
FY2024 4.1× (16.54%)
FY2023 4.9× (5.42%)
FY2022 5.2× (24.94%)
FY2021 6.9× 17.89%
FY2020 5.9× 19.89%
FY2019 4.9× 18.54%
FY2018 4.1× 25.83%
FY2017 3.3× 18.15%
FY2016 2.8× (11.63%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 3.1× (10.12%)
Mar 2026 3.4× (17.88%)
Dec 2025 4.1× (9.19%)
Sep 2025 4.6× (2.43%)
42 more quarters

Against its own ten years

Low 2.3× High 7.2×
Ten-year median 4.5×
Current reading's percentile 27

P/B ratio against peers

Company P/B ratio
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.4×
BSX Boston Scientific Corporation compare 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.9×
STE STERIS plc compare 3.0×
ABT Abbott Laboratories 3.5×
EW Edwards Lifesciences Corporation compare 4.7×
SYK Stryker Corporation compare 4.7×
DXCM DexCom, Inc. compare 12.5×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ABT